XT
TCRT icon

XTX Topco’s Alaunos Therapeutics TCRT Stock Holding History

XTX Topco’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.1K Buy
+10,174
New +$30.4K ﹤0.01% 3464
2022
Q4 		– Sell
-158
Closed -$41K – 1499
2022
Q3 		$41K Buy
+158
New +$45.9K 0.01% 1039
2022
Q1 		– Sell
-294
Closed -$48K – 946
2021
Q4 		$48K Buy
+294
New +$64.6K 0.03% 570
2021
Q3 		– Sell
-320
Closed -$127K – 1051
2021
Q2 		$127K Buy
320
+189
+144% +$88.2K 0.04% 629
2021
Q1 		$71K Buy
+131
New +$81.6K 0.03% 596

Other funds holding TCRT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return